PAM
FLXN

Paradigm Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Paradigm Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,950
Closed -$66.7K – 886
2014
Q2 		$66.7K Buy
+4,950
New +$67.5K 0.01% 686

Other funds holding FLXN

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paradigm Asset Management's FLXN Position: Q3 2014 in Review

Paradigm Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2014, closing a stake of 4,950 shares — an estimated $66.7K sold.

Paradigm Asset Management first reported a position in FLXN in Q2 2014 and held it in 1 quarter. The position peaked at $66.7K in Q2 2014. 38 funds tracked by Wall St. Rank hold FLXN as of Q3 2014.

  • Paradigm Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Paradigm Asset Management sold 4,950 Flexion Therapeutics, Inc. shares in Q3 2014, an estimated $66.7K.
  • Paradigm Asset Management first reported a position in Flexion Therapeutics, Inc. in Q2 2014 and held it in 1 quarter.
  • Paradigm Asset Management's Flexion Therapeutics, Inc. position peaked at $66.7K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2014.

Based on Paradigm Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.